Impact of Fatty Liver Disease on Cholesterol in Adolescents with Type 2 Diabetes
Author Information
Author(s): Orozco Morales José Antonio, Medina Urrutia Aída Xochitl, Tamayo Margarita Torres, Reyes Barrera Juan, Galarza Esteban Jorge, Juárez Rojas Juan Gabriel, Dies Suarez Pilar, Méndez Sánchez Nahum, Díaz Orozco Luis Enrique, Velázquez-López Lubia, Medina Bravo Patricia
Primary Institution: Hospital Infantil de México Federico Gómez
Hypothesis
What is the impact of metabolic-associated fatty liver disease (MAFLD) on cholesterol efflux capacity in adolescents with type 2 diabetes?
Conclusion
The presence of MAFLD in adolescents with type 2 diabetes does not affect cholesterol efflux capacity, but it is linked to changes in HDL particle distribution and composition.
Supporting Evidence
- 66% of adolescents with type 2 diabetes had MAFLD.
- Initial slight elevation of cholesterol efflux capacity was observed in adolescents with diabetes.
- Positive correlation between liver fat percentage and certain HDL subtypes.
- Negative correlation between liver fat percentage and cholesterol esters in HDL particles.
Takeaway
This study looked at kids with diabetes and found that having fatty liver doesn't change how well their bodies can handle cholesterol, but it does change the types of cholesterol they have.
Methodology
A cross-sectional study comparing HDL characteristics and cholesterol efflux capacity in adolescents with and without MAFLD.
Limitations
The study's cross-sectional design limits causal inferences and did not assess nutritional factors.
Participant Demographics
70 adolescents aged 10-18, including 47 with type 2 diabetes and 23 healthy controls.
Statistical Information
P-Value
p=0.011, p=0.014, p=0.007, p=0.010, p<0.001, p=0.05
Confidence Interval
95% confidence interval: 5.5%–10.3%
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website